Is a neutrophil percentage of 46% within the normal adult range and does it require any specific intervention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Neutrophil Percentage of 46%: Assessment and Management

A neutrophil percentage of 46% falls within the normal adult reference range and requires no specific intervention in an otherwise healthy individual.

Normal Reference Range

  • The normal neutrophil percentage in adults typically ranges from 40-70% 1, 2
  • A neutrophil percentage of 46% is well within this established range and does not indicate neutropenia, neutrophilia, or any pathological state 1, 2

Clinical Context Matters

While the percentage itself is normal, interpretation requires consideration of the absolute neutrophil count (ANC), which is calculated by multiplying the total white blood cell count by the neutrophil percentage 3:

  • Neutropenia is defined as ANC <1,500 cells/μL in adults (not based on percentage alone) 4
  • Severe neutropenia occurs when ANC <500 cells/μL, which significantly increases infection risk 5
  • The percentage alone cannot determine if neutropenia exists without knowing the total WBC count 1, 2

When to Investigate Further

No intervention is needed for a 46% neutrophil percentage unless:

  • The absolute neutrophil count is <1,500 cells/μL (mild neutropenia), <500 cells/μL (moderate), or <100 cells/μL (severe) 5, 4
  • Clinical signs of infection are present (fever >38°C, tachycardia >90 bpm, tachypnea >24 breaths/min) 6
  • The patient has recent chemotherapy exposure with fever, which constitutes febrile neutropenia requiring emergent evaluation 5, 4
  • There is marked leukocytosis (WBC >14,000 cells/mm³) suggesting underlying bacterial infection 1, 2
  • A left shift is present (band neutrophils >6% or >1,500 cells/mm³), indicating acute bacterial infection 1, 2

Important Caveats

  • Race-specific variations exist: African Americans have lower baseline WBC and ANC compared to European Americans, requiring race-specific reference intervals 7
  • Sex differences occur: Women have neutrophil counts approximately 0.66 × 10⁹/L higher than men on average 8
  • Diurnal variation: Neutrophil counts are approximately 0.50 × 10⁹/L higher in the afternoon compared to morning 8

Bottom Line

A neutrophil percentage of 46% is normal and requires no action unless accompanied by an abnormal absolute neutrophil count, clinical signs of infection, or relevant risk factors such as recent chemotherapy 1, 2, 4.

Related Questions

What is the significance of a neutrophil percentage of 77.7% and how should it be evaluated?
In which conditions are neutrophil counts increased and decreased?
In a neutropenic patient with persistent fever despite 4–7 days of broad‑spectrum antibiotics, when should antifungal therapy be initiated and what is the recommended first‑line antifungal agent and dosing?
What is the appropriate evaluation and management for a 16-year-old with sickle cell trait who has leukopenia (WBC 1.7 × 10⁹/L) and neutropenia (absolute neutrophil count 604/µL)?
What is the appropriate evaluation and management for a 35-year-old Black female with a white blood cell count of 3.3 ×10⁹/L, red blood cell count of 5.25 ×10¹²/L, hemoglobin 12.4 g/dL, hematocrit 39 %, mean corpuscular volume 74.3 fL, mean corpuscular hemoglobin 23.6 pg, red cell distribution width 15.1 %, absolute monocyte count 198 cells/µL, and eosinophil count 10 cells/µL?
When restarting lisinopril, does the patient need renal function monitoring within a couple of weeks despite having taken it only two months ago?
How can I switch lamotrigine from the extended‑release (ER) formulation to the immediate‑release (IR) formulation while keeping the total daily dose the same?
When should dual orexin receptor antagonists be started in an adult with chronic insomnia after non‑pharmacologic measures have failed, and what are the recommended initial doses and safety considerations for suvorexant (Belsomra), lemborexant (Dayvigo), and daridorexant (Quviviq)?
What are the common causes of mild restrictive physiology with reduced diffusing capacity on pulmonary function tests?
Why is a chest X‑ray performed in the initial evaluation of newly diagnosed endometrial cancer?
How common is hyperpigmentation after carbon dioxide laser resurfacing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.